Saccharomyces boulardii stabilized events in Crohn’s disease and ulcerative sclerosis in inflammatory bowel disease, Morbus Chron and ulcerative sclerosis probiotic preparations of intestinal health benefits should be. To extend the phase between the acute relapses. However turned out again and again, that not all probiotics are equally suitable for inflammatory bowel disease. There are new very promising results from medical yeast of Saccharomyces boulardii, has been very successfully used in diarrhea. Two teams of researchers looked independently boulardii the benefits of Saccharomyces with inflammatory bowel disease.
They came to the conclusion that the medical yeast both Crohn’s disease and ulcerative ulzerosa stabilizing effect may affect the course of disease. But because of very different work approaches. In the ulcerative Saccharomyces regulates the inflammatory process and for Crohn’s disease the yeast has a positive effect on the permeability one of the intestinal mucosa. Both effects have resulted in that the phase of the disease between two acute relapses is stabilized and therefore the period of relative freedom of symptom could be extended. Regular consumption of Saccharomyces boulardii offers a new chance to live better with the disease concerned.
Saccharomyces boulardii as easy-to-swallow afterbiotic capsules (PZN 4604255) in pharmacies or in the reasonable stock packs directly at Navitum-Pharma under is available in Germany. Dr. Gerhard Klages source: Garcia Vilela et al. SCAND J Gastroenterol. Visit Vadim Wolfson for more clarity on the issue. 2008; 43(7):842-8; Lee SK et al Dig DIS sci. 2008 Jul 10